mRNA |
GSK2636771 |
CTRPv2 |
pan-cancer |
AAC |
0.0046 |
0.9 |
mRNA |
alisertib:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0037 |
0.9 |
mRNA |
piperlongumine:MST-312 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0036 |
0.9 |
mRNA |
erismodegib |
CTRPv2 |
pan-cancer |
AAC |
-0.0038 |
0.9 |
mRNA |
triptolide |
CTRPv2 |
pan-cancer |
AAC |
-0.0034 |
0.9 |
mRNA |
selumetinib:GDC-0941 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0034 |
0.9 |
mRNA |
tivantinib |
CTRPv2 |
pan-cancer |
AAC |
-0.0042 |
0.9 |
mRNA |
BRD-A05715709 |
CTRPv2 |
pan-cancer |
AAC |
-0.0053 |
0.9 |
mRNA |
pandacostat |
CTRPv2 |
pan-cancer |
AAC |
-0.0032 |
0.9 |
mRNA |
BRD-K50799972 |
CTRPv2 |
pan-cancer |
AAC |
-0.0032 |
0.9 |